Related references
Note: Only part of the references are listed.Cell-of-origin in diffuse large B-cell lymphoma: findings from the UK's population-based Haematological Malignancy Research Network
Daniel Painter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
Solene M. Evrard et al.
HAEMATOLOGICA (2019)
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
Daisuke Ennishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Using Gene Expression Profiling to Move Beyond MYC/BCL2 Rearrangements in High-Grade Lymphoma
Wing C. Chan
JOURNAL OF CLINICAL ONCOLOGY (2019)
Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy
Chulin Sha et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
Alexandra Smith et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality
Francesco Cucco et al.
LABORATORY INVESTIGATION (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma
A. Bouska et al.
LEUKEMIA (2017)
MYC Modulation around the CDK2/p27/SKP2 Axis
Per Hydbring et al.
GENES (2017)
Tailoring front-line therapy in diffuse large B-cell lymphoma: who should we treat differently?
Andrew Davies
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Anupama Reddy et al.
CELL (2017)
BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab
Sarah Huet et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma
Allison Rosenthal et al.
BLOOD REVIEWS (2017)
Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus
E. Leich et al.
LEUKEMIA (2016)
MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice
Michael J. Kluk et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma
Zijun Y. Xu-Monette et al.
CLINICAL CANCER RESEARCH (2016)
Double hit lymphoma: from biology to therapeutic implications
Mauricio Burotto et al.
EXPERT REVIEW OF HEMATOLOGY (2016)
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study
Robert Kridel et al.
PLOS MEDICINE (2016)
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study
Christiane Copie-Bergman et al.
BLOOD (2015)
Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing
Ming Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas A Retrospective Cohort Study
Ana-Iris Schiefer et al.
MEDICINE (2015)
Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas
Chulin Sha et al.
GENOME MEDICINE (2015)
A common functional consequence of tumor-derived mutations within c-MYC
A. A. Chakraborty et al.
ONCOGENE (2015)
The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit
Alexandra Clipson et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2015)
MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations
Mette O. Pedersen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Alexandar Tzankov et al.
MODERN PATHOLOGY (2014)
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
Jessica Okosun et al.
NATURE GENETICS (2014)
IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples
Frency Varghese et al.
PLOS ONE (2014)
Genetics of Follicular Lymphoma Transformation
Laura Pasqualucci et al.
CELL REPORTS (2014)
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
Heike Horn et al.
BLOOD (2013)
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
Shimin Hu et al.
BLOOD (2013)
Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
Carlo Visco et al.
HAEMATOLOGICA (2013)
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
David Cunningham et al.
LANCET (2013)
A Microarray Platform-Independent Classification Tool for Cell of Origin Class Allows Comparative Analysis of Gene Expression in Diffuse Large B-cell Lymphoma
Matthew A. Care et al.
PLOS ONE (2013)
Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome
Sharon L. Barrans et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Frequencies of BCL2 and BCL6 Translocations in Representative Chinese Follicular Lymphoma Patients: Morphologic, Immunohistochemical, and FISH Analyses
Yi Pan et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2012)
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Tina Marie Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Nathalie A. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
Sharon Barrans et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Follicular Lymphoma of the Thyroid Gland
Chris M. Bacon et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads
Kai Ye et al.
BIOINFORMATICS (2009)
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
Kerry J. Savage et al.
BLOOD (2009)
Immuno-Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study
Christiane Copie-Bergman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment
E. C. Obermann et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region
Keni Gu et al.
MODERN PATHOLOGY (2009)
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
MT Hemann et al.
NATURE (2005)
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
G Wright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli
F Kuttler et al.
ONCOGENE (2001)
c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover
F Bahram et al.
BLOOD (2000)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
